Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
NCT05274243Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxybenzylamine in rheumatoid arthritis (RA), sponsored by Vanderbilt University Medical Center. Started Aug 2022; status: completed.
02
Drugs
2-hydroxybenzylamine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05274243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274243.